International Biotechnology Trust Stock Operating Margin
| IBT Stock | 686.00 8.00 1.18% |
International Biotechnology Trust fundamentals help investors to digest information that contributes to International Biotechnology's financial success or failures. It also enables traders to predict the movement of International Stock. The fundamental analysis module provides a way to measure International Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to International Biotechnology stock.
International | Operating Margin |
International Biotechnology Trust Company Operating Margin Analysis
International Biotechnology's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current International Biotechnology Operating Margin | 0.90 % |
Most of International Biotechnology's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, International Biotechnology Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, International Biotechnology Trust has an Operating Margin of 0.8958%. This is 95.14% lower than that of the Capital Markets sector and 96.54% lower than that of the Financials industry. The operating margin for all United Kingdom stocks is 116.26% lower than that of the firm.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
International Biotechnology ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, International Biotechnology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to International Biotechnology's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
International Fundamentals
| Return On Equity | 0.0625 | ||||
| Return On Asset | 0.0357 | ||||
| Profit Margin | 0.75 % | ||||
| Operating Margin | 0.90 % | ||||
| Current Valuation | 279.36 M | ||||
| Shares Outstanding | 36.45 M | ||||
| Shares Owned By Insiders | 1.42 % | ||||
| Shares Owned By Institutions | 44.59 % | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 6.41 X | ||||
| Revenue | 40.14 M | ||||
| Gross Profit | (13.58 M) | ||||
| EBITDA | 39.55 M | ||||
| Net Income | 38.88 M | ||||
| Total Debt | 22.83 M | ||||
| Book Value Per Share | 7.49 X | ||||
| Cash Flow From Operations | 45.35 M | ||||
| Earnings Per Share | 0.48 X | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 246.91 M | ||||
| Total Asset | 308.15 M | ||||
| Retained Earnings | (54.03 M) | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 308.15 M | ||||
| Last Dividend Paid | 0.28 |
About International Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze International Biotechnology Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of International Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of International Biotechnology Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in International Stock
International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.